KFDA to improve labeling and descriptions of prescription drugs

Published: 2002-12-10 06:59:00

Updated: 2002-12-10 06:59:00

The Korea Food and Drug Administration (KFDA) plans to improve labeling and descriptions of prescription drugs in addition to OTC products, so as to ensure that both doctors and pharmacists can accurately recognize the properties of drugs for correct prescription of drugs and drug guidance theret...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK